Prodrugs of clopidogrel's active metabolite identified by Shanghai Curegene Pharmaceutical Feb. 24, 2022
Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases Feb. 23, 2022
Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists Feb. 22, 2022
RSS